Is the Secukinumab Market Driving a New Era in Autoimmune Disease...

أضاف وظيفة جديدة أخرى

2026-02-26 10:31:10 -

Is the Secukinumab Market Driving a New Era in Autoimmune Disease Treatment?

The Secukinumab Market is emerging as a critical force in the global biologics landscape as autoimmune disorders continue to rise worldwide. The Secukinumab market was valued at USD 5,389 Million in 2023 and is projected to grow to USD 8,445 Million by 2034, registering a compound annual growth rate (CAGR) of 4.3% from 2024 to 2030. This growth reflects the increasing reliance on targeted...

0 التعليقات 0 المشاركات 109 مشاهدة 0 معاينة